期刊
EXPERIMENTAL CELL RESEARCH
卷 332, 期 2, 页码 236-246出版社
ELSEVIER INC
DOI: 10.1016/j.yexcr.2014.11.021
关键词
Gallbladder cancer; Hispidulin; HIF-1 alpha; P-gp; Chemosensitivity
资金
- National Natural Science Foundation [81473384, 31470570]
- Qingdao University [14-2-3-50-nsh, 13-1-3-74, 600201304]
Gallbladder cancer (GBC) is an aggressive malignancy of the bile duct, which is associated with a low (5-year) survival and poor prognosis. The transcription factor HIF-1 alpha is implicated in the angiogenesis, cell survival, epithelial mesenchymal transition (EMT) and invasiveness of GBC. In this study, we have investigated the role of HIF-1 alpha in the pathobilogy of GBC and effect of hispidulin on the molecular events controlled by this transcription factor. We observed that hispidulin caused induction of apoptosis, blockade of growth and cell cycle progression in GBC cells. Our results have demonstrated for the first time that hispidulin-exerted anti-tumor effect involved the suppression of HIF-1 alpha signaling. Hispidulin was found to repress the expression of HIF-1 alpha protein dose-dependently without affecting the HIF-1 alpha mRNA expression. In addition, the inhibition of HIF-1 alpha protein synthesis was revealed to be mediated through the activation of AMPK signaling. Hispidulin also sensitized the tumor cells to Gemcitabine and 5-Fluoroucil by down-regulating HIF-1 alpha/P-gp signaling. Given the low cost and exceedingly safe profile, hispidulin appears to be a promising and novel chemosensitizer for GBC treatment. (C) 2014 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据